GENOVA, Inc.
9341.TJPXHealthcareMedical - Healthcare Information Services
Latest quote
¥640
+¥15.00 · +2.40%
9341.T company overview
Regular session · JST · Market data may be delayed.
Company profile
Company websiteOperating within Japan, GENOVA, Inc. focuses on the digital healthcare market, providing both medical platform services and smart clinic solutions. Its offerings include Medical Doc, a comprehensive online platform that distributes diverse content, such as articles for healthcare institutions, patient experience narratives, treatment demonstrations, and general medical information. The company also developed Smart Clinic, an innovative telemedicine and consultation service that enables users to receive medical care from their homes or workplaces, bypassing the need for in-person hospital visits. Additionally, GENOVA offers a suite of clinic automation tools, including NOMOCa-Stand, a user-friendly automatic machine for reception and payments; NOMOCa-Regi, a dedicated self-pay terminal for clinic environments; and CLINIC BOT, an AI-driven chatbot system. GENOVA, Inc. was established in 2005 and is based in Tokyo, Japan.
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- Headquarters
- JP
- CEO
- Tomoki Hirase
- Listed since
- Dec 23, 2022
- Employees
- 529
Market position
Day range
Current ¥640
52-week range
Current ¥640
- Open
- ¥625
- Previous close
- ¥625
- Volume
- 78.7K
- 1.28× average
- Average volume
- 61.48K
- Average daily volume
- Market cap
- 11.1B JPY
- Beta
- -0.13
- Market reference 1
- 50-day average
- ¥606.72
- +5.49% above average
- 200-day average
- ¥588.3
- +8.79% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 4.95B JPY
- P/E (TTM)
- 17.79×
- P/B (TTM)
- 1.8×
- P/S (TTM)
- 0.87×
- EV / EBITDA
- 9.1×
- Earnings yield
- 2.89%
- Free cash flow yield
- -0.49%
- Dividend yield
- 4.69%
Profitability & efficiency
- Gross margin
- 52.93%
- Operating margin
- 2.76%
- Net margin
- 4.88%
- Return on equity
- 3.99%
- Return on assets
- 2.69%
- Return on invested capital
- 2.61%
Financial health
- Debt / equity
- 0.29×
- Current ratio
- 3.73×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 11.57B JPY | 10.01B JPY | 8.68B JPY | 6.51B JPY | 4.8B JPY |
| Cost of goods sold | 5.1B JPY | 2.63B JPY | 2.13B JPY | 1.72B JPY | 1.3B JPY |
| Gross profit | 6.47B JPY | 7.38B JPY | 6.55B JPY | 4.79B JPY | 3.5B JPY |
| Research and development | — | 151.14M JPY | 46.87M JPY | 29.19M JPY | 33.66M JPY |
| Selling, general, and administrative | 6.07B JPY | 5.2B JPY | 4.2B JPY | 3.03B JPY | 2.41B JPY |
| Operating expenses | 6.07B JPY | 5.35B JPY | 4.25B JPY | 3.06B JPY | 2.44B JPY |
| Interest income | 14.46M JPY | 3.77M JPY | 82K JPY | 137K JPY | 160K JPY |
| Interest expense | 5.25M JPY | 530K JPY | 555K JPY | 1.52M JPY | 2.15M JPY |
| Depreciation and amortization | 143.48M JPY | 79.95M JPY | 73.71M JPY | 54.26M JPY | 38.58M JPY |
| Operating income | 400.38M JPY | 2.03B JPY | 2.3B JPY | 1.73B JPY | 1.06B JPY |
| Net income | 275.4M JPY | 1.41B JPY | 1.73B JPY | 1.26B JPY | 686.27M JPY |
Company facts updated Aug 24, 2026.
Earnings
- Latest EPS result
- 14.4
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
9341.T peers
ETFs holding 9341.T
Funds reporting this stock among their holdings, ordered by reported position size.
Continue in GoAI
Research 9341.Tresearch.disclaimer